Empiric therapy for the immunocompromised host.

  title={Empiric therapy for the immunocompromised host.},
  author={Donald Armstrong},
  journal={Reviews of infectious diseases},
  volume={13 Suppl 9},
The use of empiric therapy for immunocompromised hosts has been one of the major advances in the management of such patients. Such therapy has been put into practice primarily for patients with neutropenia induced by cytotoxic chemotherapy. The empiric antibiotic regimens include in their coverage the bowel, skin, and intravenous-catheter flora anticipated for patients in a particular hospital. Less often, physicians treat empirically for opportunistic infections that complicate defects in… CONTINUE READING